functional constipation. Constipation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The ability to participate in the whole study Absence of significant behavioral disorders Speech in understandable language Completion of the consent form and having at least six months of history of constipation according to Rome III criteria.
Exclusion criteria
Exclusion criteria: Sensitivity to herbal medicines Diagnosis of obstructive constipation by a gastroenterologist based on history or colon transit Consumption drugs that cause constipation in the recent month (anticholinergic drugs, tricyclic antidepressants, calcium channel blockers, anti-Parkinson's drugs, sympathomimetics, antipsychotics, diuretics, iron supplements, anti-inflammatory drugs, hormonal drugs) Abuse narcotics, stimulants, cannabis, alcohol and pseudo pirates Illnesses affecting constipation Warning signs (rectal bleeding, weight loss or anemia) Unpredictable complications were leading to intolerance to the drug or placebo such as idiosyncratic disease Secondary constipation to diseases, and medications Gastrointestinal complications that impede the continuation of the study Unwilling to continue the study and lack of cooperation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Straining during at least 25% of defecations. Timepoint: The end of 1, 2, 3 months, and three months after the end of the intervention. Method of measurement: A questionnaire filled out by the researcher using the interview method.;Lumpy or hard stools in at least 25% of defecations. Timepoint: The end of 1, 2, 3 months, and three months after the end of the intervention. Method of measurement: A questionnaire filled out by the researcher using the interview method.;The sensation of incomplete evacuation for at least 25% of defecations. Timepoint: The end of 1, 2, 3 months, and three months after the end of the intervention. Method of measurement: A questionnaire filled out by the researcher using the interview method.;Sensation of anorectal obstruction/blockage for at least 25% of defecations. Timepoint: The end of 1, 2, 3 months, and three months after the end of the intervention. Method of measurement: A questionnaire filled out by the researcher using the interview method.;Manual maneuvers to facilitate at least 25% of defecations (e.g., digital evacuation, support of the pelvic floor). Timepoint: The end of 1, 2, 3 months, and three months after the end of the intervention. Method of measurement: A questionnaire filled out by the researcher using the interview method.;Fewer than three defecations per week. Timepoint: The end of 1, 2, 3 months, and three months after the end of the intervention. Method of measurement: A questionnaire filled out by the researcher using the interview method.;Loose stools are rarely present without the use of laxatives. Timepoint: The end of 1, 2, 3 months, and three months after the end of the intervention. Method of measurement: A questionnaire filled out by the researcher using the interview method.;Patient satisfaction. Timepoint: The end of 1, 2, 3 months, and three months after the end of the intervention. Method of measurement: Using the visual analogue scale questionnaire, ten scores were filled in by the researcher using t | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences